Aldeyra Therapeutics, Inc. (ALDX) — Net Income

Annual figures by fiscal year, from SEC filings.

2013: $13.06M2014: -$5.19M2015: -$12.09M2016: -$18.70M2017: -$22.34M2018: -$38.89M2019: -$60.83M2020: -$37.55M2021: -$57.78M2022: -$62.02M2023: -$37.54M2024: -$55.85M2025: -$33.85M-$33.85M
2013Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$33.85M+39.4%
2024-$55.85M-48.8%
2023-$37.54M+39.5%
2022-$62.02M-7.4%
2021-$57.78M-53.8%
2020-$37.55M+38.3%
2019-$60.83M-56.4%
2018-$38.89M-74.1%
2017-$22.34M-19.5%
2016-$18.70M-54.7%
2015-$12.09M-133.1%
2014-$5.19M-139.7%
2013$13.06M